切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2017, Vol. 11 ›› Issue (13) : 1987 -1992. doi: 10.3877/cma.j.issn.1674-0785.2017.13.006

所属专题: 文献

循证医学

胺碘酮联合螺内酯与单用胺碘酮治疗阵发性房颤的Meta分析
雷芾华1, 程文波2, 龚辉1, 张峰1, 侯月梅2,()   
  1. 1. 210508 上海,复旦大学附属金山医院心内科
    2. 201499 上海,上海交通大学附属第六人民医院南院老年科
  • 收稿日期:2016-12-23 出版日期:2017-07-01
  • 通信作者: 侯月梅
  • 基金资助:
    国家自然科学基金(81670308); 上海市卫计委重点项目(20134009)

Meta-analysis of effectiveness and safety of amiodarone combined with spirolactone versus amiodarone alone in treatment of paroxysmal atrial fibrillation

Fuhua Lei1, Wenbo Cheng2, Hui Gong1, Feng Zhang1, Yuemei Hou2,()   

  1. 1. Department of Cardiology, Affiliated Jinshang Hospital of Fudan University, Shanghai 201499, China
    2. Department of Geriatrics, Southern Branch of the Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 210508, China
  • Received:2016-12-23 Published:2017-07-01
  • Corresponding author: Yuemei Hou
  • About author:
    Corresponding author: Hou Yuemei, Emai:
引用本文:

雷芾华, 程文波, 龚辉, 张峰, 侯月梅. 胺碘酮联合螺内酯与单用胺碘酮治疗阵发性房颤的Meta分析[J/OL]. 中华临床医师杂志(电子版), 2017, 11(13): 1987-1992.

Fuhua Lei, Wenbo Cheng, Hui Gong, Feng Zhang, Yuemei Hou. Meta-analysis of effectiveness and safety of amiodarone combined with spirolactone versus amiodarone alone in treatment of paroxysmal atrial fibrillation[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(13): 1987-1992.

目的

系统评价胺碘酮联合螺内酯与单用胺碘酮治疗阵发性房颤的临床效果及安全性。

方法

计算机检索中国生物医学文献数据库、中国期刊全文数据库、维普数据库、万方数据库、PubMed、Cochrane Library,查找所有比较胺碘酮联合螺内酯与单用胺碘酮对阵发性房颤患者治疗的随机对照试验。检索时间均为建库至2016年10月。同时手工检索纳入文献的参考文献。按纳入排除标准由两名研究者独立进行筛选,并提取资料,采用改良的Jadad量表评价纳入研究的质量,采用RevMan 5.3软件进行Meta分析。

结果

共纳入4篇文献,均为随机对照研究,总共388例患者。Meta分析结果显示:观察12个月,与单用胺碘酮(对照组)相比,胺碘酮联合螺内酯(试验组)具有更好的窦性心律维持率(OR = 0.38,95% CI:0.22~0.67,P = 0.0007),并且可以显著延缓左心房内径扩大(WMD =-1.72,95% CI:-2.14~-1.30,P<0.000 01),而两者安全性无统计学差异(OR = 0.66,95% CI:0.11~4.03,P = 0.65)。

结论

胺碘酮联合螺内酯比单用胺碘酮能够更好地维持窦性心律,并且能够延缓左心房内径扩大;而两组安全性无显著差异。受纳入研究的数量及质量所限,该结论仍需开展更大样本、多中心的随机对照试验加以论证。

Objective

To systematically review the effectiveness and safety of amiodarone combined with spirolactone versus amiodarone alone in the treatment of paroxysmal atrial fibrillation.

Methods

The databases of PubMed, Cochrane Library, WanFang Data, CNKI, and VIP were searched by computer to identify articles published up to October 2016 that reported randomized controlled trials (RCTs) on amiodarone combined with spirolactone versus amiodarone alone for treating paroxysmal atrial fibrillation. Two reviewers independently screened the literature according to the inclusion and exclusion criteria, extracted the data, and assessed the methodological quality of the included studies using the modified Jadad scale. Then meta-analysis was conducted using RevMan5.3 software.

Results

Four RCTs involving 388 patients were included. The meta-analysis showed that compared with the single use of amiodarone (control group), the combination treatment (test team) was associated with comparable safety (OR = 0.66, 95% CI: 0.11-4.03, P = 0.65), significantly higher maintenance rate of sinus rhythm (OR = 0.38, 95% CI: 0.22-0.67, P = 0.0007), and significantly delayed enlargement of left atrial diameter (WMD =-1.72, 95% CI: -2.14--1.30, P<0.000 01).

Conclusion

The existing evidence suggests that amiodarone combined with spirolactone is better than amiodarone alone in the treatment of paroxysmal atrial fibrillation with regard to increasing the maintenance rate of sinus rhythm and significantly delaying the enlargement of left atrial diameter, although their safety is comparable.

表1 胺碘酮联合螺内酯与单用胺碘酮治疗房颤Meta分析纳入文献基本情况
图1 胺碘酮联合螺内酯与单用胺碘酮治疗房颤12个月窦性心律维持情况的Meta分析结果(森林图)
图2 胺碘酮联合螺内酯与单用胺碘酮治疗房颤6个月窦性心律维持情况的Meta分析结果(森林图)
图3 胺碘酮联合螺内酯与单用胺碘酮治疗房颤6个月左心房内径的Meta分析结果(森林图)
图4 胺碘酮联合螺内酯与单用胺碘酮治疗房颤12个月左心房内径的Meta分析结果(森林图)
图5 胺碘酮联合螺内酯与单用胺碘酮治疗房颤12个月不良反应发生率的Meta分析结果(森林图)
图6 基于窦性心律维持率的漏斗图
[1]
Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators [J]. N Engl J Med, 2000, 342(13): 913-320.
[2]
January CT, Wann LS, Alpert JS, et al. 2014AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [J]. J Am Coll Cardiol,2014, 64(21): e1-76.
[3]
刘伟利,王桂芳. 螺内酯联合胺碘酮治疗非瓣膜病阵发性心房颤动的临床研究 [J]. 中国心血管病研究杂志, 2008, 6(10): 764-766.
[4]
张志权. 螺内酯联合胺碘酮治疗阵发性心房颤动110例 [J]. 中国药物与临床, 2015, 15(2): 263-264.
[5]
程晓静. 胺碘酮联合螺内酯治疗非瓣膜病阵发性心房颤动疗效和安全性研究 [J]. 中国医药, 2009, 4(10): 750-752.
[6]
钟伟文. 螺内酯联用胺碘酮治疗阵发性房颤临床观察 [J]. 中国社区医师: 医学专业, 2010, 12(8): 29.
[7]
Han M, Zhang Y, Sun S, et al. Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials [J]. J Cardiovasc Pharmacol, 2013, 62(4): 405-415.
[8]
Heijman J, Voigt N, Nattel S, et al. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression [J]. Circ Res, 2014, 114(9): 1483-1499.
[9]
Corradi D. Atrial fibrillation from the pathologist′s perspective [J]. Cardiovasc Pathol, 2014, 23(2): 71-84.
[10]
孙艺红. 非瓣膜病心房颤动转复窦性心律复发影响因素的研究 [J]. 中国心脏起搏与心电生理杂志, 2005, 19(3): 172-174.
[11]
Berglund H, Boukter S, Theodorsson E, et al. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions inpatients with chronic atrial fibrillation [J]. Br Heart J, 1990, 64(1): 9-13.
[12]
陈明龙. 心力衰竭与室性心律失常 [J]. 中华心律失常学杂志, 2008, 12(1): 59-62.
[13]
Kamyshnikova LA, Efremova OA. Structural and functional changes in myocardium of patients with chronic heart failure treated with spironolactone [J]. Klin Med(Mosk), 2012, 90(5): 25-28.
[14]
Lijnen PJ, van Pelt JF, Fagard RH. Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts [J]. Cardiovasc Ther, 2012, 30(1): e1-8.
[15]
Hafizi S, Wharton J, Chester AH, et al. Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts [J]. Cell Physiol Biochem, 2004, 14(4-6): 285-292.
[16]
Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, et al. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade [J]. Heart, 2013, 99(5): 320-326.
[17]
冯惠清,崔炜. 醛固酮对新生大鼠心肌成纤维细胞分泌ET、NO功能的影响 [J]. 中国应用生理学杂志, 2005, 21(1): 78-80.
[18]
Heijman J, Voigt N, Nattel S, et al. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression [J]. Circ Res, 2014, 114(9): 1483-1499.
[19]
Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation [J]. Circulation, 2009, 119(13): 1758-1767.
[20]
葛文芳. 用胺碘酮联合螺内酯治疗持续性心房纤颤的疗效研究 [J]. 当代医药论丛, 2014, 12(19): 295-296.
[21]
郭志琴,刘坤申,彭应心. 心力衰竭的醛固酮逃逸现象及螺内酯干预 [J]. 中华心血管病杂志, 2001, 29(11): 660-662.
[22]
夏立志. 醛固酮受体拮抗剂在预防心房颤动复发中的作用及对心房重构的影响 [J]. 航空航天医学杂志, 2013, 24(12): 1450-1452.
[23]
Singh BN, Singh SN, Reda DJ, et al. Amiodarone versus sotalol for atrial fibrillation [J]. N Engl J Med, 2005, 352(18): 1861-1872.
[1] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[3] 吴义刚, 潘裕民, 吴姗姗, 胡梦涓, 王一为, 张劲松, 乔莉. 左西孟旦治疗肺动脉高压合并右心衰竭患者疗效分析——Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 385-391.
[4] 张秋阳, 余韶芸, 潘向滢, 金家佳, 夏桦, 赵雪红. 成年体外膜肺氧合患者出血影响因素的Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 392-398.
[5] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[6] 郭仁凯, 武慧铭, 李辉宇. 机器人辅助全系膜切除术治疗右半结肠癌有效性和安全性的Meta分析及试验序贯分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 234-240.
[7] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[8] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[9] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[10] 王利航, 孙官文, 包呼和, 倪熙宇, 张万印, 黄斐, 杨鹏波. 三种手术方式治疗肩锁关节脱位疗效的网状Meta 分析[J/OL]. 中华肩肘外科电子杂志, 2024, 12(04): 332-343.
[11] 郁凯, 曾保起, 杨剑, 杨杰, 张殿英, 孙凤. 全关节镜与切开手术治疗肩袖撕裂疗效比较的系统综述与Meta分析[J/OL]. 中华肩肘外科电子杂志, 2024, 12(03): 238-245.
[12] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[13] 周倩妹, 王宪娥, 徐筱, 老慧琳, 赵欣悦, 胡菁颖. 多元化系统护理对老年人群牙周健康指标影响的系统评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 500-506.
[14] 郑屹, 刘莹, 张煜坤, 李广平, 陈康寅, 刘彤. 既往及新发心房颤动对急性心肌梗死患者远期卒中风险的影响[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 406-417.
[15] 李芳, 戴西望, 王凯, 郭廷昊, 涂江龙. 非瓣膜性心房颤动相关性卒中的治疗研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 393-397.
阅读次数
全文


摘要